Human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025

The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025.

Human microbiome market is segmented by product, disease and application. The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. The disease segment of the human microbiome market is broadly segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders and other diseases. The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics.
The human microbiota is the collection of microorganisms lives on or within any of a number of human tissues and bio fluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, biliary and gastrointestinal tracts. The report would be of an interest to various stakeholders operating in the human microbiome market. These stakeholders include hospitals, research institutes, medical device suppliers, academic institutes, manufacturers, market research and consulting firms.

Get PDF Sample Copy of Research Report: http://bit.ly/2UuEm7C

The List of Companies

1. Enterome
2. MicroBiome Therapeutics, LLC
3. Rebiotix Inc.
4. Yakult Honsha Co., Ltd.
5. Osel Inc.
6. Vedanta Biosciences, Inc.
7. Metabiomics Corporate
8. Synthetic Biologics, Inc.
9. DuPont,
10. BiomX Ltd.

The objective of the study is to describe, define, and forecast the human microbiome market by product, disease, application and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting human microbiome market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key human microbiome manufacturing companies along with their SWOT analysis and market strategies.

Get Discount on this Report@ http://bit.ly/2TuwK5f

The major players operating in the human microbiome market include Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, and BiomX Ltd. For instance, in January 2018, Rebiotix Inc. collaborated with CoreBiome, to measure the ability of RBX2660 and RBX7455 to rehabilitate the human microbiome impacted by recurrent Clostridium difficile (C. diff) infection. And the collaboration expanded the geographical presence of the company in global human microbiome market.

About Us
The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.
We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.

The Insight Partners,
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: http://www.theinsightpartners.com/

This release was published on openPR.